Kristiansen G - Search Results

1

Diagnostic and prognostic molecular biomarkers for prostate cancer.

Kristiansen G. Kristiansen G. Histopathology. 2012 Jan;60(1):125-41. doi: 10.1111/j.1365-2559.2011.04083.x. Histopathology. 2012. PMID: 22212082 Review.

2

CD24 expression is a new prognostic marker in breast cancer.

Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M. Kristiansen G, et al. Clin Cancer Res. 2003 Oct 15;9(13):4906-13. Clin Cancer Res. 2003. PMID: 14581365

3

CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.

Kristiansen G, Pilarsky C, Pervan J, Stürzebecher B, Stephan C, Jung K, Loening S, Rosenthal A, Dietel M. Kristiansen G, et al. Prostate. 2004 Feb 1;58(2):183-92. doi: 10.1002/pros.10324. Prostate. 2004. PMID: 14716744

4

Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.

Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, Roepcke S, Dahl E, Hinzmann B, Specht T, Pervan J, Stephan C, Loening S, Dietel M, Rosenthal A. Kristiansen G, et al. J Pathol. 2005 Feb;205(3):359-76. doi: 10.1002/path.1676. J Pathol. 2005. PMID: 15532095

5

Expression of AGR2 in non small cell lung cancer.

Fritzsche FR, Dahl E, Dankof A, Burkhardt M, Pahl S, Petersen I, Dietel M, Kristiansen G. Fritzsche FR, et al. Among authors: kristiansen g. Histol Histopathol. 2007 Jul;22(7):703-8. doi: 10.14670/HH-22.703. Histol Histopathol. 2007. PMID: 17455144

6

Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.

Fritzsche FR, Thomas A, Winzer KJ, Beyer B, Dankof A, Bellach J, Dahl E, Dietel M, Kristiansen G. Fritzsche FR, et al. Among authors: kristiansen g. Histol Histopathol. 2007 Nov;22(11):1221-30. doi: 10.14670/HH-22.1221. Histol Histopathol. 2007. PMID: 17647195

7

ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.

Fritzsche FR, Jung M, Tölle A, Wild P, Hartmann A, Wassermann K, Rabien A, Lein M, Dietel M, Pilarsky C, Calvano D, Grützmann R, Jung K, Kristiansen G. Fritzsche FR, et al. Among authors: kristiansen g. Eur Urol. 2008 Nov;54(5):1097-106. doi: 10.1016/j.eururo.2007.11.034. Epub 2007 Nov 26. Eur Urol. 2008. PMID: 18061337

8

CD146 protein in prostate cancer: revisited with two different antibodies.

Fritzsche FR, Wassermann K, Rabien A, Schicktanz H, Dankof A, Loening SA, Dietel M, Jung K, Kristiansen G. Fritzsche FR, et al. Among authors: kristiansen g. Pathology. 2008 Aug;40(5):457-64. doi: 10.1080/00313020802197996. Pathology. 2008. PMID: 18604730

9

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics.

Kristiansen G, Fritzsche FR, Wassermann K, Jäger C, Tölls A, Lein M, Stephan C, Jung K, Pilarsky C, Dietel M, Moch H. Kristiansen G, et al. Br J Cancer. 2008 Sep 16;99(6):939-48. doi: 10.1038/sj.bjc.6604614. Br J Cancer. 2008. PMID: 18781151 Free PMC article.

10

Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma.

Riener MO, Pilarsky C, Gerhardt J, Grützmann R, Fritzsche FR, Bahra M, Weichert W, Kristiansen G. Riener MO, et al. Among authors: kristiansen g. Histol Histopathol. 2009 Sep;24(9):1121-8. doi: 10.14670/HH-24.1121. Histol Histopathol. 2009. PMID: 19609859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters